The short version
4 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.0978 per unit over the past year.
Market view
oxybutynin · Tablet, Film Coated, Extended Release
39 marketed package NDCs · 4 active manufacturers
Most dispensed: CHLORIDE 10 mg · Tablet, Film Coated, Extended Release · #100 tablet, film coated, extended releases/bottle · CHLORIDE 15 mg · Tablet, Film Coated, Extended Release · #100 tablet, film coated, extended releases/bottle · CHLORIDE 5 mg · Tablet, Film Coated, Extended Release · #100 tablet, film coated, extended releases/bottle · CHLORIDE 10 mg · Tablet, Film Coated, Extended Release · #500 tablet, film coated, extended releases/bottle
Price range and competition
RSS: changes for this drugEvery company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.
Latest · Sep 2026 — typical price $0.0978 · middle half $0.0817–$0.0978 · full range $0.0817–$0.1253 · 5 products · 4 companies
ⓘ How this was built
Data sources
- CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
- CMS Federal Upper Limit files (weighted AMP)
- FDA NDC Directory (openFDA) — maker roster
Method
Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
What changed in the last 90 days
Every detected change for oxybutynin, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- oxybutyninAug 19, 2026Price upNADAC $0.1188 → $0.12525 per unit (+5.43%)
- oxybutyninAug 19, 2026Price downNADAC $0.09895 → $0.09784 per unit (-1.12%)
- oxybutyninAug 19, 2026Price downNADAC $0.09895 → $0.09784 per unit (-1.12%)
- oxybutyninAug 19, 2026Price downNADAC $0.08374 → $0.08166 per unit (-2.48%)
- oxybutyninAug 19, 2026Price downNADAC $0.08374 → $0.08166 per unit (-2.48%)
- Oxytrol for WomenAug 19, 2026Price upNADAC $2.74248 → $2.74968 per unit (+0.26%)
- Oxytrol for WomenAug 19, 2026Price upNADAC $2.74248 → $2.74968 per unit (+0.26%)
- OxytrolAug 19, 2026Price downNADAC $81.53429 → $81.49094 per unit (-0.05%)
- Oxytrol for WomenJul 22, 2026Price upNADAC $2.72913 → $2.74248 per unit (+0.49%)
- oxybutyninJul 22, 2026Price downNADAC $0.08749 → $0.08374 per unit (-4.29%)
Same drug class
Other molecules FDA puts in Cholinergic Muscarinic Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- atropine sulfate injection· in shortage
- atropine sulfate monohydrate· in shortage
- atropine· in shortage
- atropine sulfate· in shortage
- aconitum napellus, adrenalinum, agaricus muscarius, apis mellifica, atropinum, camphora, cantharis, causticum, cerebrum suis, chamomilla, cicuta virosa, cuprum metallicum, homarus, hyoscyamus niger, hypophysis suis, lac caninum, moschus, stramonium, tarentula hispana, veratrum album· 1 maker
- adrenal drops· 1 maker
- ammi vis, atropinum sulphuricum, boldo, carduus mar, chelidonium maj, echinacea, fel tauri, hepar suis, hydrastis, leptandra, mag phos, nat phos, podoph pelt, taraxacum· 1 maker
- ammi visnaga, atropinum sulphuricum, boldo, carduus marianus, chelidonium majus, echinacea, fel tauri, hepar suis, hydrastis canadensis, leptandra virginica, magnesia phosphorica, natrum phosphoricum, podophyllum peltatum, taraxacum officinale· 1 maker
- apis mellifica, cantharis, chamomilla, adrenalinum, cerebrum suis, hypophysis suis, aconitum napellus, agaricus muscarius, atropinum, causticum, cicuta virosa, cuprum metallicum, hyoscyamus niger, lac caninum, moschus, stramonium, tarentula hispana, veratrum album, homarus, camphora· 1 maker
- arg nitd3, atropin sulphd6, bufo rand10, cuprum aceticd3, oenanthe crocd5, zinc valeriand2· 1 maker
- argentum nitricum, atropinum sulphuricum, aurum muriaticum natronatum, bos taurus ovary, bos taurus pancreas, bos taurus pituitarum posterium, bos taurus uterus, cimicifuga racemosa, estrone, helonias dioica, progesterone, pulsatilla vulgaris, sabina, sepia, sequoiadendron giganteum whole, sus scrofa pineal gland, sus scrofa spleen, thiosinaminum, thyroidinum, viburnum opulus· 1 maker
- arsenic albd7, atropin sulphd6, blatta orid3, grindeliad3, ipecacd6, naphthalinumd7, spongia tostad4· 1 maker
Common questions
- Is Oxybutynin in shortage right now?
- No. FDA does not currently list Oxybutynin in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Oxybutynin?
- 6 companies have marketed Oxybutynin in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Oxybutynin cost?
- The typical pharmacy pays about $0.1115 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.